Accepted abstracts

Accepted abstracts

See the first research works accepted for presentation at CannX 2018 and their allocation per categories. 

Do not miss the chance to be among them and submit your abstract now! 


SCI TRACK :Theoretical/General Aspects:

CANNX18-0020
DEPRESSION AND ANXIETY AMONG CHRONIC PAIN PATIENTS AND ITS ASSOCIATION TO PROBLEMATIC USE OF MEDICAL MARIJUANA

D. Feingold1, S. Bril2, I. Goor-Aryeh3, Y. Delayahu4,5, S. Lev-Ran5,6
1Airel University, Department of Psychology and Behavioral Sciences, Ariel, Israel
2Sourasky Medical Center, Pain Center, Tel Aviv, Israel
3Sheba Medical Center, Pain Center, Tel Hashomer, Israel
4Abarbanel Mental Health Center, Department of Dual Diagnosis, Tel Aviv, Israel
5Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel
6Lev-Hasharon Medical Center, Dual Diagnosis Clinic, Pardesiya, Israel

-----------------------------------------------------------------------------------------------------------

CANNX18-0023
CO-CULTURE, STIGMA AND DEPRIVATIONS AMONG MEDICAL CANNABIS PATIENTS IN ISRAEL

H. Bonny-Noach1
1Ariel University, Department of Criminology, Ariel, Israel

------------------------------------------------------------------------------------------------------------

CANNX18-0031
BRIDGING THE GAP: THE NEED FOR AN INSTITUTE ON CANNABIS FOR MENTAL HEALTH AND WELL-BEING

J. Marcu1
1International Research Center for Cannabis and Mental Health, Research, New York, USA

------------------------------------------------------------------------------------------------------------

CANNX18-0032
KNOWLEDGE AND ATTITUDES ABOUT CANNABIS AMONG MENTAL HEALTH CLINICIANS

J. Roberts1,2, J. Marcu1
1International Research Center on Cannabis and Mental Health, Translational Research, New York, USA
2New York University, Silver School, New York, USA

------------------------------------------------------------------------------------------------------------

CANNX18-0037
UTILIZATION OF MEDICAL CANNABIS OBSERVATIONAL DATA TO DESIGN RANDOMIZED CLINICAL TRIALS: THE SANTÉ CANNABIS MODEL

E. Prosk1, A. Vigano2
1Santé Cannabis, Research, Montreal, Canada
2McGill Univerity, Oncology, Montreal, Canada

------------------------------------------------------------------------------------------------------------

SCI TRACK: Practical Aspects:

CANNX18-0024 
FUNGI GET "HIGH" WITH THE SYNTHETIC CANNABINOID HU-210 ?
D. Steinberg1, R. Smoun2, R. Mechoulam2, M. Feldman1
1Hebrew University, Biofilm Research Laboratory, Jerusalem, Israel
2Hebrew University, Pharmacy, Jerusalem, Israel

------------------------------------------------------------------------------------------------------------

CANNX18-0025
PRIMUM NON NOCERE – SAFETY OF MEDICAL CANNABIS USE IN THE ELDERLY

R. Abuhasira1, I. Sikorin2, A. Ron2, S. Ben-Hamo2, V. Novack1
1Ben Gurion University of the Negev and Soroka Medical Center, Cannabis Clinical Research Institute, Beer-Sheva, Israel
2NiaMedic Geriatric Clinic, NiaMedic Geriatric Clinic, Bnei Brak, Israel

------------------------------------------------------------------------------------------------------------

CANNX18-0033
NEW FRONTIERS IN TREATING CHRONIC INSOMNIA IN CANADIAN VETERANS WITH PTSD: RETROSPECTIVE ANALYSIS REVEALS AN INNOVATIVE ROLE FOR MEDICAL CANNABIS IN OPTIMIZING SLEEP/WAKE HEALTH

C. Thirlwell1, K. Rainville2, D. Miri1, A. Donath3, H. Shulman4
1Sleep Wake Awareness Program SWAP, Psychiatry & Sleep Medicine, Toronto, Canada
2Canna Connect, Cannabis Educator & Veteran Advocate, Ste Emelie de L'Energie, Canada
3Tilray, Clinical Relations Manager, Toronto, Canada
4Sleep Wake Awareness Program SWAP, Research and Statistical Analysis, Toronto, Canada

------------------------------------------------------------------------------------------------------------

CANNX18-0034
MEDICAL CANNABIS OIL: RESULTS FROM THE FIRST-IN-HUMAN PHASE 1, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY

M.F. Arboleda1,2, E. Prosk2, G. Chamberland3, A. Vigano1,2
1McGill University Health Center, Oncology- Supportive and Palliative Care Division, Montreal, Canada
2Santé Cannabis, Research, Montreal, Canada
3Tetra Bio-Pharma, Research, Montreal, Canada

------------------------------------------------------------------------------------------------------------

CANNX18-0035
CANNABIS USE AS AN ALTERNATIVE FOR OPIOIDS, ANTIPSYCHOTICS AND ANTIDEPRESSANTS AMONG GERIATRIC PATIENTS IN A LONG-TERM CARE SETTING: A CASE SERIES

B. Pearson1
1Greenly Health Ltd., Medical Research, Sarnia- Ontario, Canada

------------------------------------------------------------------------------------------------------------

BIZ: New Technologies, New Opportunities

CANNX18-0012

CANNABINOIDS IN DENTISTRY FUTURE REVOLUTIONARY CONCEPT IN DENTAL TREATMENTS
V. Stahl1
1Cannabite Life Long/ Euro Dent Belgium bvba, Dentistry, Mortsel, Belgium

------------------------------------------------------------------------------------------------------------

CANNX18-0013

CANNABINOIDS IN DENTISTRY FUTURE REVOLUTIONARY CONCEPT IN DENTAL TREATMENTS
V. Stahl1
1Cannabite Life Long/ Euro Dent Belgium bvba, Dentistry, Mortsel, Belgium

------------------------------------------------------------------------------------------------------------

CANNX18-0014

BRINGING NATURE BACK TO AGRICULTURE: PROMISE, POSSIBILITIES AND CHALLENGES OF USING MICROBIAL BIOSTIMULANTS TO ENHANCE PRODUCTIVITY
C. Bell1
1Growcentia / Mammoth Microbes, Research and Development, Fort Collins, USA

------------------------------------------------------------------------------------------------------------

CANNX18-0022
ULTRASOUND-ASSISTED EXTRACTION OF CANNABINOIDS FROM CANNABIS SATIVA L.

L. Csoka1
1University of Sopron, Institute of Wood Based Products nad Technologies, SOPRON, Hungary

------------------------------------------------------------------------------------------------------------

CANNX18-0026
VIRTUAL REHABILITATION CENTRE (VRC), AN INTEGRATIVE, MULTI-MODAL FOLLOW-UP TOOL FOR CHRONIC PAIN

Boshyk1S. Mosaad2, R. Marques3
1Psychotherapist, Pain Management, Toronto, Canada
2Centres for Pain Managment, Pain Managment, Toronto, Canada
3Centres for Pain Managment, Chiropractor, Toronto, Canada

------------------------------------------------------------------------------------------------------------

AGR: Advanced Agriculture and Production

CANNX18-0027
PROS AND CONS OF CLONING PROPAGATION AND HOW TO SHIFT TO SEED PRODUCTION

H. Less1
1Yarok-MedTech Ltd., Co-Founder, Orot, Israel

------------------------------------------------------------------------------------------------------------



CANNX18-0018
MICROGLIAL SIGNALING IN AUTISM SPECTRUM DISORDERS WITH PHYTOCANNABINOIDS
C. Bogner1, T. O.-Peterson1
1Oxford Recovery Center, Arts - Autism Recovery Thru Synergy division, Brighton- MI, USA
---------------------------------------------------------------------------------------------------------------
CANNX18-0019
REDUCTION OF BENZODIAZEPINE USE IN PATIENTS PRESCRIBED MEDICAL MARIJUANA
C. Purcell1, N. Moolman2, A. Davis3, S.M. Taylor4
1Dalhousie University, Undergraduate Medical Education, Halifax, Canada
2Dalhousie University, Department of Surgery- Division of Otolaryngology – Head and Neck Surgery-, Halifax, Canada
3Acadia University, Department of Economics, Wolfville, Canada
4Dalhousie University, Department of Surgery- Division of Otolaryngology – Head and Neck Surgery, Halifax, Canada
----------------------------------------------------------------------------------------------------------------
CANNX18-0021
A THERAPEUTIC EFFECT OF CANNABIDIOL (CBD)-ENRICHED OINTMENT IN INFLAMMATORY SKIN DISEASES AND CUTANEOUS SCARS
M. Vadalà1, B. palmieri1, C. laurino1
1University of Modena, surgery, Modena, Italy
----------------------------------------------------------------------------------------------------------------
CANNX18-0028
A NEW FORMULATION OF CANNABIDIOL AND CHITOSAN FOR THE TREATMENT OF DYSLIPIDEMIA AND WEIGHT GAIN
D. Robinson1S. Prutchi Sagiv2, N. Ben Shalom3
1Rabin Medical Center, Orthopedics, Petach Tikvah, Israel
2CannaLean, R&D, Bnei Brak, Israel
3CannaLean, Chemistry, Bnei Brak, Israel
----------------------------------------------------------------------------------------------------------------
CANNX18-0029
EXAMINING THE SAFETY AND OPIOID SPARING EFFECT OF MEDICAL CANNABIS AMONG CHRONIC PAIN PATIENTS
R. Duarte1, S. Thirunavukkarasu1, N. Lopez1, N. Rosen1
1North Shore University Hospital/Northwell Health, Neurology, Manhasset, USA
----------------------------------------------------------------------------------------------------------------
CANNX18-0030
ASSESSMENT OF THE ANTI-INFLAMMATORY EFFECTS OF CANNABIDIOL AND ITS NOVEL SEMI-SYNTHETIC DERIVATIVES IN RAW 264.7 MACROPHAGES
N. Miltner1, J. Mihaly1, G. Beke1, E. Hollosi1, B. Zara1, K. Jambrovics2, R. Mechoulam3,4, T. Biro1,4
1University of Debrecen, Department of Immunology- Faculty of Medicine, Debrecen, Hungary
2University of Debrecen, Department of Biochemistry and Molecular Biology- Faculty of Medicine, Debrecen, Hungary
3The Hebrew University, Institute for Drug Research- Medical Faculty, Jerusalem, Israel
4Phytecs, Ltd., Los Angeles, USA
----------------------------------------------------------------------------------------------------------------
CANNX18-0038
PTSD & INSOMNIA: POLYSOMNOGRAPHIC EVIDENCE OF CHANGES IN SLEEP ARCHITECTURE AND SLEEP/WAKE FUNCTIONING WITH MEDICAL CANNABIS TREATMENT
D. Miri1, A. Donath2, C. Thirlwell1
1Sleep Wake Awareness Program SWAP, Psychiatrist & Sleep Medicine, Toronto, Canada
2Tilray, Clinical Relations Manager, Toronto, Canada
----------------------------------------------------------------------------------------------------------------